Searchable abstracts of presentations at key conferences in endocrinology

ea0025p300 | Steroids | SFEBES2011

Concurrent analysis of 10 serum steroids by mass spectrometry: investigation of the viability of the Perkin-Elmer CHS™ MSMS steroids kit on a waters xevo mass spectrometer with acquity UPLC system

Taylor Angela , Shackleton Cedric , Taylor Stuart , Jensen Ulrich Glumer , Ojala Marko , Arlt Wiebke

Steroids present in human serum can be used to identify a number of conditions such as congenital adrenal hyperplasia, Addison’s disease and Cushing’s disorder. Historically this has been completed using immunoassays; currently there is a move towards mass spectrometry which reduces analysis time, cross reactivity and improves sensitivity. When mass spectrometers are coupled with liquid chromatography systems (LC–MS) it is possible to monitor a number of steroid...

ea0035oc10.4 | Endocrine Tumours | ECE2014

Mast cell interactions at tumour interface drive progression in human prostate cancer

Risbridger Gail , Ellem Stuart , Taylor Renea , Frydenberg Mark , Pook David , Pedersen John , Bioresource APC , Hashimoto Kohei , Seach Natalie , Clark Ashlee , Hutmacher Dietmar , Pardo Elena

Introduction: Prostate cancer is hormone dependent and regulated by a balance of androgens as well as estrogens. Regulatory control is also exerted by the tumor microenvironment including cancer-associated fibroblasts (CAFs), and immune cells. Although patient derived xenografts (PDX) commonly used to study the functional effects of CAFs, the method is not quantitative, is lengthy, technically challenging and the xenografts are placed in immune suppressed hosts excluding immun...